Looking at the universe of stocks we cover at Dividend Channel, on 4/7/14, Eagle Materials Inc (EXP - Get Report) will trade ex-dividend, for its quarterly dividend of $0.10, payable on 5/7/14. As a percentage of EXP's recent stock price of $89.00, this dividend works out to approximately 0.11%.Below is a dividend history chart for EXP, showing historical dividends prior to the most recent $0.10 declared by Eagle Materials Inc: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from EXP is likely to continue, and whether the current estimated yield of 0.45% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of EXP shares, versus its 200 day moving average: Looking at the chart above, EXP's low point in its 52 week range is $60.25 per share, with $91.88 as the 52 week high point — that compares with a last trade of $89.26. According to the ETF Finder at ETF Channel, EXP makes up 1.82% of the iShares U.S. Home Construction ETF ( ITB) which is trading lower by about 0.5% on the day Thursday. In Thursday trading, Eagle Materials Inc shares are currently down about 0.3% on the day.
More from Stocks
Apple, Coca-Cola, Snap, Facebook, Debt Ceiling - 5 Things You Must Know
U.S. stock futures rise ahead of earnings reports from a number of corporate heavyweights and after the White House and congressional negotiators reach a budget deal that will lift the government's debt limit; Coca-Cola, Snap, Visa and Harley-Davidson are among the companies reporting earnings on Tuesday; Apple reportedly is in talks to buy Intel's modem chip business for $1 billion.
What to Watch When Snap Reports Its Latest Results
Snap's user trends have stabilized, and its revenue has grown this year. Can it keep up the pace?
Acadia Falls Sharply in After-Hours Trading After Schizophrenia Drug Fails Study
Stock drops as Pimavanserin study finds no statistically significant improvement in adult schizophrenia patients.